Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-19

Clinical Trial Update: Ultrasound for the Detection of Oxaliplatin-Induced Peripheral Neuropathy [NA]

View source ↗

Summary

A completed study evaluating ultrasound as a method to detect oxaliplatin-induced peripheral neuropathy in patients with gastrointestinal or colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Gastrointestinal Cancer, Colorectal Cancer | NA | Status: COMPLETED